chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Chest pain on left side of chest and under left shoulder blade. Lightheaded, shortness of breath, resting heart rate in the 130's, and when I would walk, it would shoot up to the 160's. Dizzy, heart pounding, trouble breathing. Went to an urgent care that wouldn't see me, but they asked which vaccine I had because they had multiple people come in after their booster shots with those same symptoms. Went to another urgent care, they did an EKG, and chest xray and both were clear. they were highly concerned about the tachycardia, so they sent me to the emergency room. At the ER they did another EKG, and blood work to rule out a blood clot in my lungs. They could not figure out why my heart rate was still so high, when my blood pressure, temp and everything else was normal. They gave me fluids, ibuprofen, and something to calm my heart down (i dont remember the name) and told me that I needed to follow up with a cardio doctor to check my heart out.
Information has been received from a nurse concerning a 14 month old patient who on 19-APR-2012 was vaccinated with a dose of VARIVAX (Merck) (lot# 670169/1574AA). The nurse mentioned that on 14-JUN-2012 the patient had outbreaks of varicella. The patient had contacted the office. At the time of the report, the patient's status was unknown. This was one of the several reports from the same source. A lot check has been initiated. The follow up information has been received from a registered nurse refers to a 14 months (reported also as 1 year old) old male patient. The patient's medical history included eczema. Current conditions included hearing problems and cleft palate cleft lip bilateral, completed and none illness at the time of the vaccination. The patient was vaccinated subcutaneously in left leg with a first dose of VARIVAX, (dose not reported; lot # (670169/1574AA) on 19-APR-2012. It was reported that on 14-JUN-2012 the patient came to the clinic with rash described as "multiple erythematous patches with vesicles, have localized over knees and elbows. All stages of vesicles were present from ulcers to fresh blisters." The patient was diagnosed with the varicella. No lab tests were performed. The patient's recovered from varicella on 02-JUL-2012. This is one of several reports from the same source. Additional information is not expected.
This is a spontaneous report from a contactable pharmacist via a Pfizer sales representative. A patient of unspecified age and gender received PREVNAR 13 (lot number and expiration date unknown) via an unspecified route of administration on an unspecified date at a single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient experienced redness at injection site on an unspecified date. It was reported that event took place after use of pneumococcal 13-valent conjugated vaccine (diphtheria crm197 protein). The outcome of the event was unknown. The following information on the batch number has been requested.
Vaccine recipient  received second dose of Moderna vaccine 14 days early.  Dose 1 given 4/9/21 Dose 2 given 4/23/21 Vaccine recipient was immediately notified by clinical lead of early dosing. He was observed for reaction in observation area, no adverse reaction observed or reported. Telephone call to vaccine recipient 24 later, he stated he feels fine. No headache, body aches, fever, or other symptoms reported. Vaccine recipient said he went to work and denies any adverse reactions.
something wrong with the liver; A spontaneous report was received from a consumer concerning patients of unspecified age and gender who received Moderna's COVID-19 vaccine (mRNA-1273) and were dying after second shot and something wrong with the liver (liver disorder).  The patients' medical histories were not provided. No relevant concomitant medications were reported.  Dates of vaccination were not reported. The reported heard on the news that "people are dying after the second shot" and apparently one of the patients had something wrong with the liver after getting the shot.  The reporter said the patients received Moderna's mRNA-vaccine.  On an unknown date, the patient experienced the event(s) people are dying after second shot,   No treatment information was provided.  The action taken with the vaccine in response to the events was not applicable.  The cause of death for "one of the patients was had something wrong with the liver".; Reporter's Comments: Very limited information regarding this event has been provided at this time.  Further information has been requested; Reported Cause(s) of Death: liver disorder; death unknown cause
Shortness of breath; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath ) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (Shortness of breath ). At the time of the report, DYSPNOEA (Shortness of breath ) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication were provided. No concomitant medication were provided.
There was blood in my stool the evening following vaccination and the morning after vaccination. After those two instances, the problem was no longer observed. I did not seek medical treatment because the problem did not persist for more than a day.
Information has been received from a 31 year old female licensed practical nurse with reaction/allergy to DEMEROL and a history of function kidney decreased who on 05-JUL-2007 was vaccinated with a dose of RECOMBIVAX HB through her shoulder bone on her "humeral head" arm area. There was no concomitant medication. On 05-JUL-2007 the patient's shoulder was sore and bled on the injection site. The pain eventually went away. One week later, the burning pain appeared and went down to her elbow. The patient got an MRI and it showed 2 cm hematoma in the bone marrow. X-ray and lab test also performed (results not provided). The patient has about 11 to 24% loss the mobility of her arm. At the time of this report, the patient was not recovered. Loss of mobility was considered to be disabling, because she could not move the arm. The patient saw the physician for medical attention. Additional information has been requested.
Severe body and joint aching lasting 2days.  Also red rash covering the bicep warm to the touch.
7/4/2021: Patient transferred from Hosptial after presenting with generalized weakness, cough, shortness of breath and blood in the urine.  Patient tested positive for COVID on 7/3/2021.   Diagnosed with acute bilateral pneumonia secondary to COVID-19, acute hypoxic resp failure, severe ARDS, acute metabolic encephalopathy, AKI. intubated in the ICU.  Note: patient fully vaccinated with Moderna COVID-19 vaccine.  7.25.21: patient died.
lt arm swollen area of inj swollen, size of baseball;hot to touch;no other sx-viewed by RN in clinic;
Received DTaP, IPV in (R) thigh 8/32/10. 8/24/10 complaining of leg pain, difficulty walking. In office 8/24/10, 09:15 appears mildly ill, pale, walks slowly and favors (R) leg. Complained of abdominal pain and vomited once in office. (R) thigh tender to palpation, indurated. No warmth or erythema.
On day 16 post-injection, I started experiencing left sided pins/needles/numbness.  I went to the ER and they did a CT and CTA which was normal.  The next day or so I went to neurology who ordered blood tests (Lyme's, Vitamin deficiencies, Sjrogen's antigens, CRP, ferritin, Copper, ACE, TSH, Vitamin D , ANA) that were all negative.  Next I had a MRI of the head and spine with and without contrast which was normal.  The pins and needs have now spread all over my body.  I full body neuropathic pain (burning sensation, numbness, tingling, sharp pain like stabbing, left eye pain, feeling like bugs are walking on me, and zapping pain).  Neurology is continuing to work up my symptoms but they were new onset after COVID vaccine.
This spontaneous report as received from a physician via a company representative refers to a female patient of unknown age. The patient's pertinent medical history and drug reactions or allergies were not reported. On an unknown date, the patient was vaccinated intramuscularly with an unknown dose of GARDASIL 9 (lot# and expiry date were not reported). Concomitant medication included PPD test, which was performed on the same day as vaccination. On an unknown date, after the procedures were completed, the patient experienced syncope. The patient was observed for an unspecified amount of time and was released. The patient did not seek medical attention. It was unknown if the subsequent doses of GARDASIL 9 would be continued. The outcome of syncope was unknown. The relatedness between syncope and GARDASIL 9 was not reported. Additional information has been requested.
10 days after I received the vaccine I present a  maculopapular rash that begins in my face and spread to my neck and chest in 24 hours after appears, the itching increase after sun exposure. Also I notice a retroauricular adenopathy retroauricular left ear. No fever no malaise, pain 3/10 intensity, right elbow.
About 45mins after vaccination I had rigor. This was not normal chills. I did not have a fever. I did feel warm. I was very pale. The next morning around 06:30AM it happened again for about 30mins. Two days later it came back again and I ended up going to urgent care. I had been expecting I had a UTI. I was started on Keflex 500mg four times a day. By the following day all my symptoms are gone. I do still experience fatigue.
This is a spontaneous report based on the information received by Pfizer from Merck & Co., Inc. (01035471). A contactable healthcare professional on behalf of a pharmacist reported similar events for 3 patients. This is 3rd of three reports. A patient of unspecified age and gender started to receive PREVNAR 13, via an unspecified route of administration in Sep2018 at a single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient developed severe injection site redness, rash, and soreness in 2018. The outcome of the events was unknown. No follow-up attempts are possible, information about batch number cannot be obtained. Sender's Comments: Linked Report(s): US-PFIZER INC-2018525839 same reporter, drug, event, and different patient; US-PFIZER INC-2018525856 same reporter, drug, event, and different patient.
SV for unstable angina; CAD; Tachycardia; Nausea; Belching; SOB; Chest heaviness, chest pressure, chest tightness; Pain; This is a spontaneous report from a non-contactable other HCP. A 70-year-old female patient received the first dose of bnt162b2 (lot number EN6205) via unspecified route of administration on unspecified date at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications was not provided. Upon 15 minutes after injection, she noted nausea with belching and had some SOB. Symptoms worsened as she ambulated over to the medical bay along with her chest pressure. She denied rash, hives, welts, hoarseness, stridor, itching, lightheadedness, dizziness, facial swelling, lip swelling and tongue swelling. Patient reported recently admitted for unstable angina and CAD with tachycardia. Patient had elevated d-dimer and blood clot was ruled out. Patient discontinued on new medication, beta blocker. Since discharge this Sunday 21Feb2021, she reported chest heaviness as if she has "cardboard on chest." Can slightly increase with going up and down stairs or increased activity. She states she had reached out to her cardiologist via an online site but has not heard back. Patient stated her pain is about the same today. Patient complains of chest tightness and shortness of breath. The outcome of events was unknown.   No Follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on temporal association, the contribution of the suspect drug to the onset of events unstable angina and tachycardia cannot be excluded. The patient's age and suspected cardiac condition are risk factors. The event CAD, given its progressive nature, is most likely an underlying condition, thus unrelated to the suspect drug.   The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
Body ache; Chills; Headache; Received booster from expired vial; On 29Oct2021 they administered 15 Moderna COVID-19 booster half doses to patients; This spontaneous case was reported by a physician and describes the occurrence of MYALGIA (Body ache), CHILLS (Chills), HEADACHE (Headache), EXPIRED PRODUCT ADMINISTERED (Received booster from expired vial) and UNDERDOSE (On 29Oct2021 they administered 15 Moderna COVID-19 booster half doses to patients) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038C21A) for COVID-19 vaccination.     Previously administered products included for an unreported indication: INFLUENZA (Batch.no UT383JA,IM andleft arm on) on 12-Oct-2021. Concurrent medical conditions included Asthma, Hypertension, GERD, Anxiety, Allergy to animal dander, Environmental allergy, Sulfonamide allergy, Drug allergy and Allergy to molds. Concomitant products included AZELASTINE HYDROCHLORIDE (AZELASTIN COMOD) from 17-Jan-2020 to an unknown date for Allergy, CLONAZEPAM (KLONOPIN) from 19-Oct-2021 to an unknown date and BUPROPION from 02-May-2018 to an unknown date for Anxiety, OMEPRAZOLE (PROTONIX [OMEPRAZOLE]) from 20-Oct-2021 to an unknown date for GERD, MAGNESIUM from 23-Jan-2020 to an unknown date for an unknown indication.    On 29-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 29-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received booster from expired vial) and UNDERDOSE (On 29Oct2021 they administered 15 Moderna COVID-19 booster half doses to patients). On 30-Oct-2021, the patient experienced MYALGIA (Body ache), CHILLS (Chills) and HEADACHE (Headache). On 29-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Received booster from expired vial) and UNDERDOSE (On 29Oct2021 they administered 15 Moderna COVID-19 booster half doses to patients) had resolved. On 31-Oct-2021, MYALGIA (Body ache), CHILLS (Chills) and HEADACHE (Headache) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were reported.
5-7 days delayed face rash; swelling; itching; swelling and itching, including forearms, back of hands; fatigue; ringing in the ears; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 65-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: EN6202, Expiry date was not reported) via an unspecified route of administration, administered in Arm Right on 02Mar2021 13:30 (at the age of 65 years old) as DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. The patient had not received any other vaccine within 4 weeks. On 05Mar2021 the patient experienced, 5-7 days delayed face rash with swelling and itching, including forearms, back of hands. Accompanied by fatigue and ringing in the ears. Patient received no treatment for the events. The outcome for the events was not recovered.   No follow-up attempts are possible. No further information is expected.
the day after immunization mother reported 103 fever and febrile siezure, taken to ED , sent home with fever reducer and the following day spike fever of 105,  continues to be fatigued and sleeping more
Headaches; Ear pain; Lots of other nerve pain in my hands and legs; Inappropriate age at vaccine administration; My face started drooping / diagnosed me with Bell's palsy; Numbness in my face; This case was reported by a consumer and described the occurrence of bell's palsy in a 35-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix and the 2nd dose of Shingrix. In November 2020, not applicable after receiving Shingrix and 3 weeks after receiving Shingrix, the patient experienced numbness facial. On an unknown date, the patient experienced bell's palsy (serious criteria GSK medically significant), headache, ear pain, nerve pain and inappropriate age at vaccine administration. The patient was treated with antivirals nos and steroids nos (Steroids). On an unknown date, the outcome of the bell's palsy, numbness facial, headache, ear pain and nerve pain were not recovered/not resolved and the outcome of the inappropriate age at vaccine administration was unknown.   It was unknown if the reporter considered the bell's palsy, numbness facial, headache, ear pain and nerve pain to be related to Shingrix.  Additional details were provided as follows: The patient had reported the case for herself. The age at vaccination was not reported for the 1st dose and it could be 34 or 35 year for 2nd dose of Shingrix. The patient received 1st and 2nd dose of Shingrix before 50 years of age, which led to inappropriate age at vaccine administration. The patient started having numbness in her face about 3 weeks November 2020 after 2nd dose of shingrix, a couple weeks later her face started drooping and she had headaches and ear pain.  The patient was diagnosed me with Bell's palsy 2 months after 2nd dose. At the time of reporting, the patient was at 3 months post 2nd dose and have gone through two rounds of steroids and antivirals and symptoms were came back with lots of other nerve pain in her hands and legs. The consent to follow-up was requested.
on 11/2/22 patient reported painful lump at injection site and warm to the touch on 11/29/22 later reported injection site was oozing pus and blood.
Fever (101 deg F), increased heart rate (~90 bpm vs 60-70 bpm normally)-started on 4 Mar 21 at 1300, resolved in 2 days with assistance of Tylenol. Headache, mild fatigue-started on 4 Mar 21 at 1215, resolved in 3 days. Arm swelling and pain in upper left arm- started on 4 Mar 21 at 0700, resolved in 4 days.
1. Persistent viscous mucous accumulating between (what feels like) the back of the mouth and the nasal passages. Not relieved by anti-histamines nor decongestants. A much different feeling than seasonal allergic rhinitis, which is easily treatable.  2. Flu like symptoms after vigorous physical exercise.
Upon administration of the vaccine, RN reported about .1ml (at end of administration of vaccine) spilled out of the hub onto patient's arm (RN noted it to be a couple drops). Medical Consult team was contacted and we informed patient that per agency guidelines because more than half the dose was given we will not be revaccinating.
Migraine after shots for treatment they give me valproic acid. Lower back pain and joint pain treatment. Lower back pain and joint pain sometime treatment nothing.  05/2007 MR received for several OVs betweem 3/2/06 and 2/9/07.  Initial ER visit for c/o worsening back pain and headaches.  Sx began while pt. was overseas.  PE WNL except for pt. being overweight, tenderness at the R low back area and some swelling to the muscles of the low back noted. Weight-loss and excercise suggested. Multiple  F/Us for same. Refered to PT.   Problem list: Osteoarthritis involving the spine.  Discogenic Disease.  Chronic Headache.  Obesity.  Hypertension. Addendum: Pt. states that the "life threatening illness" is that he will have these problems for life.
Nausea; Joint pain; tired; headache; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 29Apr2021 at 10:30 (at the age of 57-year-old) as a single dose for COVID-19 immunisation. Medical history included pneumonia. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 09Apr2021 at 08:30 (at the age of 57-year-old) as a single dose for COVID-19 immunisation. The patient had no known allergies. On 30Apr2021 at 07:00, the patient experienced nausea, joint pain, was tired and had a headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events nausea, joint pain, tired and headache was resolved on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Strange side effect started 5:30 pm 3/13 date of second injection.  Felt extremely sad, depressed.  Felt like crying but couldn't cry.  Didn't know why I felt sad.  Otherwise I felt great.  Next day extremely tired, slept all day, couldn't move off the couch, had 100 degree fever, had light breakfast in am, light salad at 9:00 pm.  Again, extremely sad in the morning, but as other symptoms took over sadness went away.  The next day felt fine--no sadness, no symptoms.  (Expected other side effects, but didn't expect sadness.  I'm finding on facebook several other people felt sadness too, didn't know why.  Other symptoms were expected.)  No symptoms since.
w/in 1hr tachycardia, paleness, nausea, vomited in ER, dizziness;ER MD looked pt over-small rxn;
Starting 8/26 at 03:00AM, patient began experiencing extreme skin sensitivity over entire body. Described that "wearing a shirt felt like knives." Extreme fatigue and pain as expected post-vaccine, along with migraine headache. Pain all over body that patient described as "feeling like my entire body is bruised" with no physical presentation of bruising. Persistent nausea lasting multiple days, refractory to home remedies, responsive only to meclizine. Nausea is now manageable but still disruptive.
"Patient reports he had his 2nd covid vaccine yesterday. He noticed last night he developed fatigue, headache, fever(subjective, he does not have a thermometer). He continues to have these symptoms. After his first vaccine he had just a headache."
1:45 PM: fatigue with mild chills. 8:00 PM: severe shaking and chills, body touch very cold, headache, eye ache, muscle ache, fever 100. Treatment: hot shower followed by heating pad and bed rest. 24 hour update: fatigue.
Initial and follow up information have been received from a physician and the mother of a 24 month old white son with no pertinent medical history or drug reactions/allergies who at 10:48 on 11-DEC-2007 was vaccinated intramuscularly (site not reported) with the third 0.5 ml dose of COMVAX (lot # 657380/0377U).  There was no concomitant medication usage.  On 11-DEC-2007 the patient became very fussy.  On 13-DEC-2007 the patient developed diarrhea.  Per the patient's mother, there were no symptoms after the first 2 doses of the vaccine were given.  The patient did receive unspecified medical treatment.  No diagnostic labs test were performed.  At the time of this report the patient was recovering.  Additional information is not expected.